RxDoctor Payments Data

Arun Gupta, DO

Otolaryngology · West Des Moines, IANPI 1619382835

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,695 of the $3,334 with a category attached, or 80.8%. 24 manufacturers reported payments, led by Stryker at 26.5% of the total. Reporting peaked in 2024 at $1,441 and has fallen 59.2% since, to $588 in 2025.

$3,334in general payments, 2019–2025

Across 89 payments — averaging $37.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$882
  • Aerin Medical Inc.$440
  • Inspire Medical Systems, Inc.$428
  • Sanofi$318
  • Optinose US, Inc.$181
  • Regeneron Healthcare Solutions, Inc.$163
  • plus $921 from 18 others

What the payments were for

  • Travel & lodging$63919%
  • Food & beverage$2,69581%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,334 in reported general payments places this provider in the 80th percentile of 103 otolaryngology providers in Iowa.

See all otolaryngology providers in Iowa

Medicare billing

Part B allowed, 2024
$168,233
Medicare patients
415
Services billed
1,621

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab14$52,396
Ipratropium Bromide87$3,136
Tobramycin-DexamethasoneTobramycin/Dexamethasone32$1,750
Pantoprazole Sodium151$1,088
Clobetasol Propionate13$375
Mupirocin47$268
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav23$243
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen20$226
Omeprazole26$186
Doxycycline Monohydrate18$169
Famotidine25$77
Cephalexin15$67
Prednisone32$49

Paid to pharmacies, not to this prescriber.

Other otolaryngology in West Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →